Long-Term Outcomes Suggest a Sustained Clinical Benefit to Metastasis-Directed Treatment Over Observation in Oligometastatic Castration-Sensitive Prostate Cancer
Long-term follow-up findings from STOMP and ORIOLE and analysis of genomic predictors of response